Mölnlycke Health Care secures USD 400 million in financing

The company's re-structuring initiatives are expected to lead to annual cost savings of SEK 20 million.

Farzad Abdi-Dezfuli and his colleagues at the early-stage venture capital firm Sarsia focus their investments on therapeutics, autoimmunity/oncology/neurology, and therapy-enabling technologies that improve clinical and health-economic outcomes. 

MedCap’s wholly owned subsidiary, Unimedic Pharma, has signed an agreement to acquire XGX Pharma in Denmark.

The new factory in Turku will enable up to ten times the production capacity.

Susanna Francke Rodau and her colleagues at Segulah Medical Acceleration (SMA) have a specific focus on medical devices, diagnostics, life science tools, and health tech, and they prefer to invest in European companies that are in the beginning of their commercialization journey. 

Milla Koistinaho and her colleagues at Innovestor’s life science fund focus their investments on Nordic and Baltic-based startups that work on either transformative therapeutic opportunities addressing significant unmet medical needs, or digital solutions to inefficiencies in healthcare and providing better care and treatment.

The company receives funding support from the Gates Foundation to help the world eradicate polio (poliomyelitis) by exploring design options for a new vaccine.